Basilea Pharmaceutica Ltd. CEO Ronald Scott Retired

Basilea’s CEO Ronald Scott will retire. Chief Commercial Officer David Veitch named as successor. Changes in the Board of Directors

Basel, Switzerland, February 21, 2018 – Basilea Pharmaceutica Ltd. (SIX: BSLN) reported today that Chief Executive Officer Ronald Scott will retire…

Name: Ronald Scott

Continent: Europe

Country: Switzerland

Company: Basilea Pharmaceutica Ltd.

Branch: Pharma

Position: CEO

Reason: Retired

Announcement Date: February 20, 2018, 11:00pm

Resignation Date: February 20, 2018, 11:00pm

Source 1: https://globenewswire.com/news-release/2018/02/21/1372305/0/en/Basilea-s-CEO-Ronald-Scott-will-retire-Chief-Commercial-Officer-David-Veitch-named-as-successor-Changes-in-the-Board-of-Directors.html